Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Ubiquitin Proteasome Market by Application (Scientific Research and Cancer Treatment) - Global Opportunity Analysis and Industry Forecast, 2021-2028
| A03877 | Pages: NA | Aug 2021 | 2727 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Ubiquitin Proteasome Market
Request Now !Proteasomes are cellular complexes responsible for protein breakdown. Ubiquitin is a small protein found in all cellular tissues in humans and other eukaryotic organisms that support to regulate the processes of other proteins. Ubiquitin proteasome is a highly regulated mechanism of intracellular protein degradation, by marking proteins that are linked to ubiquitin.
The systems play a vital role in biological functions of the body such as antigen presentation, regulation of gene transcription & the cell cycle, and activation of NF-KB, which is responsible to regulate the immunological response to infections.
The development of ubiquitin proteasomes for treatment of cancer such as multiple myeloma and mantle cell lymphoma majorly drives the market. Increase in use of Ubiquitin Proteasome as a research tool in academic and industrial research center fuels the market growth. In addition, the patent expiry of Velcade (brand name of Ubiquitin Proteasome by Takeda Pharmaceutical Company Ltd) in Nov 2017 is anticipated to boost the market.
However, high cost of the drug and stringent government regulations involved in the production of Ubiquitin Proteasome hinder the growth of the market. In addition, side effects associated with ubiquitin proteasome such as low blood pressure, peripheral neuropathy, heart problems, lung problems, GIT problems, and others also restrain the market. Ongoing R&D activities related to Ubiquitin Proteasome are anticipated to present new opportunities for the market.
The market is segmented on the basis of application and region. Based on application, the market is bifurcated into scientific research and cancer treatment. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
- The study provides an in-depth analysis of the global ubiquitin proteasome market with current trends and future estimations to elucidate the investment pockets.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of different segments facilitates to understand various products of the market.
- Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.
Ubiquitin Proteasome Market Key Segments:
By Application
- Scientific Research
- Cancer Treatment
- Multiple Myeloma (A Cancer of the Plasma Cells)
- Mantle Cell Lymphoma (A Cancer of the Lymph Nodes)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
List of players profiled in the report
- Takeda Pharmaceutical Company Ltd
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd
- Novelix Pharmaceuticals, Inc
- GlaxoSmithKline Pharmaceuticals Ltd
- Onyx Pharmaceuticals, Inc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Novartis International AG
- Glenmark Pharmaceuticals Ltd
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 UBIQUITIN PROTEASOME MARKET, BY APPLICATION
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SCIENTIFIC RESEARCH
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CANCER TREATMENT
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Multiple Myeloma
4.3.4.1. Market size and forecast
4.3.5. Mantle Cell Lymphoma
4.3.5.1. Market size and forecast
CHAPTER 5 UBIQUITIN PROTEASOME MARKET, BY GEOGRAPHY
5.1. OVERVIEW
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.2.4. North America Ubiquitin Proteasome Market by Application
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.3.1. Germany market size and forecast
5.3.3.2. France market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.3.4. Europe Ubiquitin Proteasome Market by Application
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. India market size and forecast
5.4.3.4. Rest of Asia-Pacific market size and forecast
5.4.4. Asia-Pacific Ubiquitin Proteasome Market by Application
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.3.1. Latin America market size and forecast
5.5.3.2. Middle East market size and forecast
5.5.3.3. Africa market size and forecast
5.5.4. LAMEA Ubiquitin Proteasome Market by Application
CHAPTER 6 COMPANY PROFILES
6.1. TAKEDA PHARMACEUTICAL COMPANY LTD
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. JOHNSON & JOHNSON
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. F. HOFFMANN-LA ROCHE LTD
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. NOVELIX PHARMACEUTICALS, INC
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. GLAXOSMITHKLINE PHARMACEUTICALS LTD
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. ONYX PHARMACEUTICALS, INC
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. MYLAN N.V.
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. NOVARTIS INTERNATIONAL AG
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. GLENMARK PHARMACEUTICALS LTD
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Ubiquitin Proteasome Market- Global Opportunity Analysis and Industry Forecast, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers